Board of Directors

Bo Jesper Hansen (1958)

Elected 2019. Bo Jesper Hansen, born in 1958, holds an MD PhD from the University of Copenhagen, and is, inter alia, Chairman of the Board of Laborie Inc. and vice Chairman of the Board of Orphazyme A/S. Previously, Bo Jesper Hansen was Executive Chairman of the Board of SOBI AB, Chairman of the Board of Topotarget A/S, Karolinska Development AB, and Ablynx NV, board member of Hyperion Therapeutics Inc. and Gambro AB, and served as CEO of Swedish Orphan International AB. Bo Jesper Hansen is independent in relation to Karo Pharma and its management as well as in relation to the company’s major shareholders. Bo Jesper Hansen does not hold any shares in Karo Pharma.

Erika Henriksson (1981)

Elected 2019. Erika Henriksson, born in 1981, has studied business administration at the Stockholm School of Economics and is, inter alia, a board member of Eton and Director at EQT Partners and has previously been a board member of AcadeMedia and Scandic Hotels Group. Erika Henriksson is independent in relation to Karo Pharma and its management, but is not independent in relation to the company’s major shareholders. Erika Henriksson does not hold any shares in Karo Pharma.

Vesa Koskinen (1979)

Elected 2019. Vesa Koskinen, born in 1979, holds a M.Sc. (Econ.) from the Helsinki School of Economics and is, inter alia, Partner at EQT Partners and board member of Terveystalo Oyj, Touhula Oy and kfzteile24 GmbH. Previously he has been, inter alia, a board member of Roeser Group GmbH and Swiss Smile AG. Vesa Koskinen is independent in relation to Karo Pharma and its management, but is not independent in relation to the company’s major shareholders. Vesa Koskinen does not hold any shares in Karo Pharma.

Christoffer Lorenzen (1975)

Elected 2019. Christoffer Lorenzen, born in 1975, has studied marketing at Copenhagen Business School and is, inter alia, an Executive Vice President and a member of the Executive Board of Chr. Hansen Holding A/S, a board member of Hamlet Protein and vice Chairman of the Board of European Food & Feed Cultures Association. He has previously been Head of Corporate Strategy at H. Lundbeck A/S. Christoffer Lorenzen is independent in relation to Karo Pharma and its management as well as in relation to the company’s major shareholders. Christoffer Lorenzen does not hold any shares in Karo Pharma.

Åsa Riisberg (1974)

Elected 2019. Åsa Riisberg, born in 1974, holds a M.Sc in Financial Economics and Business Administration from Stockholm School of Economics and a major in International Business from Haute Etudes Commerciales (HEC) in Paris. She is a Partner at EQT Partners and a member of the Partners Committee at EQT. She has previously been a board member of, inter alia, Terveystalo Oyj, HTLSTREFA S.A., Atos Medical AB and Aleris AB. Åsa Riisberg is independent in relation to Karo Pharma and its management, but is not independent in relation to the company’s major shareholders. Åsa Riisberg does not hold any shares in Karo Pharma.

Håkan Åström (1947)

Elected 2017. Education: Master of Science in Business Administration, Stockholm School of Economics. Previous Experience: CEO Kabi Pharmacia AB, CEO Astra Pharmaceuticals Ltd., CEO Pharmacia AB. Board member SOBI (Biovitrum) and Ferrosan A/S. Board member and Vice Chairman at the Karolinska Institute. Other assignments: Chairman of the Board PledPharma AB and board member Rhenman & Partners Asset Management AB and MedUniverse AB. Other: Honorary Doctor of Medicine at Sahlgrenska Akademin, University of Gothenburg. Håkan Åström is independent in relation to Karo Pharma and its management as well as in relation to the company’s major shareholders. Håkan Åström does not hold any shares in Karo Pharma.